Family Medicine Doctors in Quitman, TX Accepting Medicare
8 Family Medicine doctors found. Showing 1 - 8
 Dr. Norman P Hicks, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 502 E Goode St Ste 1e, Quitman, TX 75783 Phone: 903-763-5402 |
 Melody Swinford, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 606 E Goode St, Suite 100, Quitman, TX 75783 Phone: 903-763-2421 Fax: 903-763-0812 |
George V Cathey Jr., MD Family Medicine Medicare: Medicare Enrolled Practice Location: 117 N Winnsboro St, Quitman, TX 75783 Phone: 903-763-2224 Fax: 903-763-2926 |
Christian Ferrer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 117 N Winnsboro St, Quitman, TX 75783 Phone: 903-763-6220 |
Dr. James Dee Dopson Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 E Goode St Ste 1e, Quitman, TX 75783 Phone: 903-763-5402 |
Beverly L Waddleton, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 108 Parker St, Ste.300, Quitman, TX 75783 Phone: 903-763-6220 Fax: 903-763-6222 |
Scott J Olson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 606 E Goode St, Suite 100, Quitman, TX 75783 Phone: 903-763-2421 Fax: 903-763-0812 |
David C Nichols, Family Medicine - Sleep Medicine Medicare: Not Enrolled in Medicare Practice Location: 606 E Goode St, Suite # 400, Quitman, TX 75783 Phone: 903-763-4709 Fax: 903-763-4709 |
News Archive
Statins and beta blockers may reduce heart attack risk
For patients with undiagnosed heart disease, taking a statin or beta blocker could mean the difference between experiencing mild chest pain, or having a full-blown heart attack as a first symptom. That's the finding of a Kaiser Permanente study in the February 21 issue of the Annals of Internal Medicine.
Syndicate of investment dealers exercise over-allotment option to purchase shares of Merus Labs International
Merus Labs International Inc. is pleased to announce today that the syndicate of investment dealers (the "Underwriters") has exercised the over-allotment option to purchase 1,000,550 common shares of the Company ("Shares") at a price of C$3.05 per Share granted to the Underwriters in connection with the Company's previously announced public offering which closed on April 30, 2015.
Zimbabwe in line to reach antiretroviral treatment target, health official says
Zimbabwe could meet its target of providing 140,000 HIV-positive people with access to no-cost antiretroviral drugs by the end of the year, Owen Mugurungi, head of the Zimbabwean government's HIV/AIDS unit, said on Tuesday at a two-day workshop on drug access issues in the country, the Herald/AllAfrica.com reports (Herald/AllAfrica.com, 10/26).
New technique makes artificial bones more natural
A new technique for producing artificial bone implants has been developed by Korean researchers. Published in the journal Science and Technology of Advanced Material (STAM), the technique combines two methods to approximate both types of bone tissue. By mimicking natural bone, it is hoped the implant material will better complement the natural regeneration process.
UAB hospital leads the way in improving antibiotic use
One of today's urgent health threats is antibiotic resistance, caused by inappropriate prescription and use of antibiotics, and — according to the Centers for Disease Control and Prevention — approximately 50 percent of all antibiotics prescribed in the United States are unnecessary or inappropriate, with many of them prescribed in inpatient settings.
› Verified 9 days ago